Herbalife 過去の業績
過去 基準チェック /16
Herbalifeの収益は年間平均-18.1%の割合で減少していますが、 Personal Products業界の収益は年間 減少しています。収益は年間0.01% 3.7%割合で 減少しています。
主要情報
-18.10%
収益成長率
-15.25%
EPS成長率
| Personal Products 業界の成長 | 20.87% |
| 収益成長率 | -3.66% |
| 株主資本利益率 | n/a |
| ネット・マージン | 4.67% |
| 次回の業績アップデート | 05 Aug 2026 |
最近の業績更新
Recent updates
ナラティブ更新 • Jun 18
HLF: Execution On 2026 Guidance And Margins Will Drive Stock Rebound
Analysts have lifted their price target on Herbalife to about $18.33 from $17.50, citing updated assumptions around discount rates, expected revenue growth, profit margins, and future P/E multiples reflected in recent research. Analyst Commentary Recent research on Herbalife highlights a mix of optimism around execution and valuation, alongside ongoing caution about the company’s ability to sustain and convert growth assumptions into consistent earnings.
ナラティブ更新 • Jun 03
HLF: Refinancing And Margin Improvement Will Support Turnaround Despite Weak EBITDA Guidance
Narrative update on Herbalife Analysts have raised their price target on Herbalife by $2, citing research that points to updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Analyst Commentary Bullish analysts raising their price target by US$2 are signaling a more constructive view on how Herbalife’s valuation lines up with its fundamentals.分析記事 • May 19
Investors Can Find Comfort In Herbalife's (NYSE:HLF) Earnings Quality
Investors were disappointed with the weak earnings posted by Herbalife Ltd. ( NYSE:HLF ). However, our analysis...Seeking Alpha • May 11
Herbalife: The Stock Wall Street Loves To Hate Is Making A Comeback
Summary Herbalife is undergoing a significant transformation, shifting from its traditional multi-level marketing model to a modern health and wellness brand. HLF is leveraging biomarker-driven personalization, direct digital health engagement, and strategic acquisitions like Bioniq and Pro2col to diversify its offerings. Recent debt refinancing and ongoing reductions have improved HLF's financial profile, with debt falling from ~$3.0B in 2021 to ~$2.18B in 2025. Wall Street has largely discounted HLF's transformation, overlooking its established brand, cash flow, and loyal customer base supporting its strategic pivot. Read the full article on Seeking Alphaナラティブ更新 • May 05
HLF: Mixed 2026 Guidance And Execution Outlook Will Shape Turnaround Prospects
Herbalife's analyst price target has been revised higher to $17.50 from $16.50, with analysts pointing to updated fair value assumptions and recent target increases at firms such as Citi, BofA and Mizuho following Q4 results and 2026 guidance. Analyst Commentary Recent research updates show a mix of optimism and caution around Herbalife, with price targets moving in different directions as analysts react to Q4 results, 2026 guidance and updated assumptions around execution and valuation.ナラティブ更新 • Apr 20
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.ナラティブ更新 • Apr 06
HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.
ナラティブ更新 • Mar 23
HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.ナラティブ更新 • Mar 09
HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks
The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.ナラティブ更新 • Feb 23
HLF: Turnaround Will Be Driven By 2026 Guidance And Margin Recovery
Narrative Update: Herbalife The updated analyst fair value estimate for Herbalife has moved from $11 to $25, a shift analysts link to refreshed price targets in the $9 to $21 range, stronger Q4 commentary, improved margin assumptions, and a lower discount rate despite mixed views on long term growth and valuation risks. Analyst Commentary Recent Street research on Herbalife reflects a mix of views, but several bullish analysts have been willing to raise price targets or upgrade their stance following recent updates from the company.ナラティブ更新 • Feb 08
HLF: Turnaround Hopes Under New Leadership Will Confront Compressed Sector Multiples
Narrative Update: Herbalife Analyst Price Target Move The blended analyst price target for Herbalife has moved higher, with recent increases such as Mizuho's lift to $13 and Maxim's initiation at $20. Analysts point to an ongoing turnaround, progress under new leadership, and a healthier long term profile for Herbalife's business model, while also noting continuing concerns about competition and broader macro uncertainty.ナラティブ更新 • Jan 25
HLF: Recovery Story Under New Leadership Will Face Compressed Sector Multiples
Narrative Update on Herbalife The analyst price target for Herbalife has been revised higher to reflect an updated fair value of $8.00, a lower discount rate of 10.02%, and adjustments to revenue growth, profit margin, and future P/E assumptions, as analysts factor in recent target hikes, Buy initiations, and views of a continuing recovery path under new leadership. Analyst Commentary Recent Street research on Herbalife reflects a mix of optimism about a potential recovery and caution around execution and valuation risks.分析記事 • Jan 22
Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth
Herbalife Ltd. ( NYSE:HLF ) shares have continued their recent momentum with a 27% gain in the last month alone. The...ナラティブ更新 • Jan 11
HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints
The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.ナラティブ更新 • Dec 25
HLF: Recovery Path Under New Leadership Will Likely Deliver Disappointing Multiple Expansion
Analysts have modestly raised their fair value estimate for Herbalife from approximately $9.67 to $12.00 per share, citing a lower perceived risk profile, steady growth and margin assumptions, and a more constructive view on future earnings multiples as fundamentals continue on a recovery path under new leadership. Analyst Commentary Analyst sentiment around Herbalife is gradually improving as execution under new leadership gains traction and forward growth expectations firm up, though views on the pace and durability of the recovery remain mixed.ナラティブ更新 • Dec 11
HLF: Recovery Path Under New Leadership Will Likely Prove Overpriced
Analysts have modestly raised their price target on Herbalife to $11 from $10, citing a gradually lower perceived risk profile, steady long term growth and margin assumptions, and growing confidence that the company is on a recovery path under new leadership, with a potential return to volume growth by fiscal 2026. Analyst Commentary Bullish analysts point to the recent rating upgrade and price target increase as evidence that sentiment around Herbalife is gradually improving, with expectations that operational execution will support a more favorable risk and reward profile over the next several years.ナラティブ更新 • Nov 27
HLF: Uncertainty Around CEO Transition Will Challenge Near-Term Momentum
Herbalife’s analyst price target has been raised to $11 from $10, as analysts point to recovering fundamentals and the company’s strategic leadership changes as promising signs for future growth. Analyst Commentary Analysts have recently weighed in on Herbalife, offering a mix of optimism about its improving fundamentals and some caution about ongoing risks.分析記事 • Nov 13
We Think That There Are Some Issues For Herbalife (NYSE:HLF) Beyond Its Promising Earnings
The market for Herbalife Ltd.'s ( NYSE:HLF ) stock was strong after it released a healthy earnings report last week...分析記事 • Oct 29
The Market Doesn't Like What It Sees From Herbalife Ltd.'s (NYSE:HLF) Earnings Yet
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...分析記事 • Sep 26
At US$8.75, Is Herbalife Ltd. (NYSE:HLF) Worth Looking At Closely?
Herbalife Ltd. ( NYSE:HLF ), might not be a large cap stock, but it saw a decent share price growth of 11% on the NYSE...分析記事 • Jul 24
A Look At The Intrinsic Value Of Herbalife Ltd. (NYSE:HLF)
Key Insights The projected fair value for Herbalife is US$9.20 based on 2 Stage Free Cash Flow to Equity Herbalife's...分析記事 • Jun 25
There's No Escaping Herbalife Ltd.'s (NYSE:HLF) Muted Earnings Despite A 26% Share Price Rise
Those holding Herbalife Ltd. ( NYSE:HLF ) shares would be relieved that the share price has rebounded 26% in the last...分析記事 • May 28
Herbalife (NYSE:HLF) Hasn't Managed To Accelerate Its Returns
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...分析記事 • May 08
Herbalife's (NYSE:HLF) Earnings Offer More Than Meets The Eye
Herbalife Ltd.'s ( NYSE:HLF ) solid earnings announcement recently didn't do much to the stock price. We did some...分析記事 • Mar 13
Herbalife Ltd.'s (NYSE:HLF) Share Price Boosted 63% But Its Business Prospects Need A Lift Too
Herbalife Ltd. ( NYSE:HLF ) shares have had a really impressive month, gaining 63% after a shaky period beforehand. But...Seeking Alpha • Feb 24
Herbalife: The Battleground Stock Is Showing Some Turnaround Potential
Summary Herbalife still operates in 95 countries using a direct selling and MLM model with six million independent distributors. Currently, HLF is facing declining sales volumes, which have been partly offset by price increases. However, it remains uncertain how sustainable this is in the long run. Post-FTC settlement, I think HLF has “sanitized” its business model, even though it has indeed made it more challenging to grow its MLM business. The good news is its focus. They have a mixed regional performance, in particular with China struggling while Asia Pacific stabilizes. Additionally, its recruitment and sales leaders numbers have been encouraging in Q4 and 2024. Based on EV/EBITDA metrics, HLF is undeniably still priced at a steep discount. However, at this point, I believe the risk-reward equation is more favorable for the bulls. Hence, I rate it a speculative “Buy” for the short term. Read the full article on Seeking Alpha分析記事 • Feb 19
Is It Time To Consider Buying Herbalife Ltd. (NYSE:HLF)?
While Herbalife Ltd. ( NYSE:HLF ) might not have the largest market cap around , it saw a double-digit share price rise...分析記事 • Jan 29
Returns At Herbalife (NYSE:HLF) Appear To Be Weighed Down
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...Seeking Alpha • Jan 21
Herbalife: Down In The Dumps, But Maybe Worth Exploring
Summary Herbalife (HLF) which offers health and wellness products across the globe has underperformed other small-caps and consumer staple stocks, while witnessing almost a 50% contraction in price over the past year. The new Chief Strategy Officer has helped revive new distributor growth after years of decline, but sales growth remains stagnant, and the outlook on the topline doesn't look too alluring. While the topline is not at full tilt, HLF's restructuring efforts are leading to a great deal of savings ($130m of aggregate savings through 2025) resulting in decent EBITDA growth. The stock is attractively priced at 4x EBITDA and an FCF yield of 27%. HLF is yet to show signs of bottom formation, although the risk-reward equation within its long-term descending channel looks favorable. Read the full article on Seeking Alpha分析記事 • Nov 12
Investors Still Aren't Entirely Convinced By Herbalife Ltd.'s (NYSE:HLF) Earnings Despite 27% Price Jump
Herbalife Ltd. ( NYSE:HLF ) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Not...分析記事 • Nov 06
We Think You Can Look Beyond Herbalife's (NYSE:HLF) Lackluster Earnings
Herbalife Ltd.'s ( NYSE:HLF ) stock was strong despite it releasing a soft earnings report last week. However, we think...収支内訳
収支内訳
Herbalife の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 26 | 5,133 | 240 | 3,491 | 0 |
| 31 Dec 25 | 5,038 | 228 | 3,431 | 0 |
| 30 Sep 25 | 4,962 | 321 | 3,789 | 0 |
| 30 Jun 25 | 4,929 | 325 | 3,784 | 0 |
| 31 Mar 25 | 4,951 | 280 | 3,787 | 0 |
| 31 Dec 24 | 4,993 | 254 | 3,426 | 0 |
| 30 Sep 24 | 5,001 | 87 | 1,823 | 0 |
| 30 Jun 24 | 5,042 | 82 | 1,832 | 0 |
| 31 Mar 24 | 5,075 | 137 | 1,833 | 0 |
| 31 Dec 23 | 5,062 | 142 | 3,471 | 0 |
| 30 Sep 23 | 5,028 | 186 | 1,783 | 0 |
| 30 Jun 23 | 5,042 | 226 | 1,777 | 0 |
| 31 Mar 23 | 5,121 | 252 | 1,794 | 0 |
| 31 Dec 22 | 5,204 | 321 | 1,798 | 0 |
| 30 Sep 22 | 5,342 | 305 | 1,879 | 0 |
| 30 Jun 22 | 5,477 | 340 | 1,923 | 0 |
| 31 Mar 22 | 5,637 | 398 | 1,959 | 0 |
| 31 Dec 21 | 5,803 | 447 | 1,999 | 0 |
| 30 Sep 21 | 5,896 | 483 | 2,014 | 0 |
| 30 Jun 21 | 5,986 | 504 | 2,054 | 0 |
| 31 Mar 21 | 5,781 | 474 | 2,033 | 0 |
| 31 Dec 20 | 5,542 | 373 | 2,075 | 0 |
| 30 Sep 20 | 5,351 | 356 | 2,068 | 0 |
| 30 Jun 20 | 5,074 | 299 | 2,039 | 0 |
| 31 Mar 20 | 4,967 | 260 | 2,035 | 0 |
| 31 Dec 19 | 4,877 | 311 | 1,921 | 0 |
| 30 Sep 19 | 4,843 | 303 | 1,898 | 0 |
| 30 Jun 19 | 4,842 | 293 | 1,897 | 0 |
| 31 Mar 19 | 4,887 | 311 | 1,931 | 0 |
| 31 Dec 18 | 4,892 | 297 | 1,955 | 0 |
| 30 Sep 18 | 4,799 | 184 | 1,901 | 0 |
| 30 Jun 18 | 4,641 | 168 | 1,847 | 0 |
| 31 Mar 18 | 4,503 | 211 | 1,780 | 0 |
| 31 Dec 17 | 4,428 | 214 | 1,759 | 0 |
| 30 Sep 17 | 4,379 | 377 | 1,749 | 0 |
| 30 Jun 17 | 4,416 | 410 | 1,745 | 0 |
| 31 Mar 17 | 4,471 | 249 | 1,978 | 0 |
| 31 Dec 16 | 4,488 | 260 | 1,967 | 0 |
| 30 Sep 16 | 4,542 | 245 | 1,995 | 0 |
| 30 Jun 16 | 4,523 | 251 | 1,987 | 0 |
| 31 Mar 16 | 4,483 | 357 | 1,780 | 0 |
| 31 Dec 15 | 4,469 | 339 | 1,785 | 0 |
| 30 Sep 15 | 4,504 | 358 | 1,752 | 0 |
質の高い収益: HLFは 高品質の収益 を持っています。
利益率の向上: HLFの現在の純利益率 (4.7%)は、昨年(5.7%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: HLFの収益は過去 5 年間で年間18.1%減少しました。
成長の加速: HLFは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: HLFは過去 1 年間で収益成長率がマイナス ( -14.5% ) となったため、 Personal Products業界平均 ( -28.8% ) と比較することが困難です。
株主資本利益率
高いROE: HLFの負債は資産を上回っているため、自己資本利益率を計算することは困難です。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/07/13 10:59 |
| 終値 | 2026/07/13 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Herbalife Ltd. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。14
| アナリスト | 機関 |
|---|---|
| John Staszak | Argus Research Company |
| Meredith Adler | Barclays |
| Brian Wang | Barclays |